Field trials of investigational new animal drugs

Veterinary and Human Toxicology

Volumn 40, Issue SUPPL. 2, 1998, Pages 48-52

  Moffitt, Christine M ^a  

^a UNIVERSITY OF IDAHO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROMYCIN; NEW DRUG;

ANIMAL FOOD; CONFERENCE PAPER; DRUG APPROVAL; DRUG EFFICACY; DRUG SAFETY; FISH; KIDNEY;

ANIMALS; ANTI-BACTERIAL AGENTS; AQUACULTURE; DRUG EVALUATION, PRECLINICAL; DRUGS, INVESTIGATIONAL; ERYTHROMYCIN; FISHES; KIDNEY; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION; VETERINARY DRUGS;

ANIMALIA; BACTERIA (MICROORGANISMS); SALMONIDAE;

EID: 0031744103     PISSN: 01456296     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (13)

1. USFDA (US Food and Drug Administration): Guidelines for the preparation of data to satisfy the requirements of Section 512 of the act regarding minor use of animal drugs. US Food and Drug Administration Center for Veterinary Medicine, Rockville, MD, 1986.
2. Moffitt CM, Haukenes AH: Regional investigational new animal drug permits for erythromycin as a feed additive and injectable drug. The Progressive Fish-Culturist 57:97-101, 1995.
3. Place VP, Majewski HS, Klaverkamp, FF: Interactions among antioxidant defenses in liver of rainbow trout (Oncorhynchus myJciss) exposed to cadmium. Canadian Journal of Aquatic Sciences 50:156-162, 1993.
4. Thompson IA, White TC, Fletcher DF et al: The effect of stress on the immune response of Atlantic salmon (Salmo salar L) fed diets containing different amounts of vitamin C. Aquaculture 114:1-18, 1993.
5. Piper RG: Toxic effects of erythromycin thiocyanate on rainbow trout. Progressive Fish-Culturist 49:134-137, 1961.
6. Warren JE: Toxicity tests of erythromycin thiocyanate in rainbow trout. Progressive Fish-Culturist 25:88-92, 1963.
7. Guarino AM, Lech JJ: Metabolism, disposition and toxicity of drugs and other xenobiotics in aquatic species. Veterinary and Human Toxicology, Supplement 1, 38-44, 1986.
8. Oshima YK, Kobayashi JF, Lumbanbatu KOoie et al: Effect of drug-metabolizing enzyme activity induced by PCB on the duration of drugs in fish. Aquaculture 120:25-31, 1994.
9. Moffitt CM, Schreck JA: Accumulation and depletion of orally administered erythromycin thiocyanate in tissues of chinook salmon. Transactions of the American Fisheries Society 117:394-400, 1988.
10. Maule AG, Tripp RA, Kattari SL et al: Stress alters immune function and disease resistance in chinook salmon (Oncorhynchus tshawtscha). Journal of Endocrinology 120:135-142, 1989.
11. Hicks BD, Geraci, JR: A histological assessment of damage in rainbow trout, Salmo gairdneri Richardson, fed rations containing erythromycin. Journal of Fish Diseases 7:457-465, 1984.
12. Periti P, Mazzei, T, Mini, E, et al: Clinical pharmacokinetic properties of the macrolide antibiotics: effects of the age and various pathophysiological states. Clinical Pharmacokinetics 16:193-214, 1989.
13. Jimenez BD, Stegeman, JJ: Detoxication enzymes as indicators of environmental stress on fish. American Fisheries Society Symposium 8:67-79, 1990.